Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion type Assertion NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_head.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion wasGeneratedBy ECO_0000203 NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_provenance.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion wasDerivedFrom befree-20150227 NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_provenance.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion SIO_000772 24757657 NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_provenance.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion evidence source_evidence_literature NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_provenance.
- NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_assertion description "[The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1008191.RACBqRz_UJ-DAiAKoILtVgmwFeC94-IfsiDVYsrDPGX7Y130_provenance.